Log in Register
Menu

Anti-Neuroblastoma [FMG25]

Invented by Dr JOHN KEMSHEAD at SHIRE PHARMACEUTICALS

Info

Catalogue Number 151730
Applications FACS
Antigen/Gene or Protein Targets Human Neuroblastoma
Reactivity Human
Relevance Useful diagnostic reagent to differentiate between neuroblastoma and rhabdomyosarcoma. May be useful as one of a panel of reagents to detect and remove tumour cells from bone marrow harvested for autologous transplantation. Also cross reacts with normal brain and peripheral nerve. The antibody does not bind to other small round-cell tumours of childhood.
Host Mouse
Immunogen Human cutaneous T cell lymphoma (HUT 78), SPF female Balb/c mice were injected i.p with 2 x 10*5 cells in complete Freund's adjuvant. 30 days later a 2nd i.p injection of 2 x 10*5 cells without adjuvant was given. Fusion was 5 days
Subclass IgG1
Myeloma Used P3X63Ag8
Strain Balb/c
Research Area Cancer, Cell Type or Organelle Marker

References: 1 entry

Gibson et al. 1987. Int J Cancer. 39(5):554-9. PMID: 3494688.


Add a reference

References: 1 entry

Gibson et al. 1987. Int J Cancer. 39(5):554-9. PMID: 3494688.


Add a reference

References: 1 entry

Gibson et al. 1987. Int J Cancer. 39(5):554-9. PMID: 3494688.


Add a reference


This reagent does not have any reviews at the moment.